RecallDepth
Class II Terminated

Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 68382-256-01) and b) 500 tablets (NDC 68382-256-05) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
September 21, 2023
Posted
October 11, 2023
Recall Number
D-0038-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
7,248 bottles
Firm Location
Pennington, NJ, United States

Reason for Recall

Failed Dissolution Specifications

Distribution

Nationwide in the USA.

Lot / Code Info

Lot#: M300652 and M300651, exp. Dec 2024

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class II Drug recalls